Park Ha Biological Technology is trading at $2.20, down 5.17% in after-hours trading, with no specific reason for the decline established.
- No verified October 23 company announcement or late-breaking catalyst explaining the drop was found.
- Recent lawsuit coverage refers to earlier September filings, not a new event.
- Broader market signals were mixed: the Nasdaq was higher, while the S&P 500 and Dow were lower, and do not clearly explain the move.